⌘K

Home/Filings/4/0001193125-25-291688

4//SEC Filing

Cheng Andrew 4

Accession 0001193125-25-291688

CIK 0001744659other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 6:25 PM ET

Size

4.6 KB

Accession

0001193125-25-291688

Insider Transaction Report

Form 4

Period: 2025-11-20

Akero Therapeutics, Inc.AKRO

DirectorPresident and CEO

Transactions

Gift
Common Stock
2025-11-20−74,538→ 436,837 total

Footnotes (1)

[F1]Represents shares of the Issuer's Common Stock that the reporting person donated as a gift to a donor advised fund.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother

Related Parties

1

filerCIK 0001778307

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 6:25 PM ET
Size: 4.6 KB

View on SEC.gov